The Inception Research Institute and The Prelude Network® are partnering in a patient registry designed to study the outcomes of non-euploid embryo transfers (NEETs).
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is widely offered as an option for patients pursuing pregnancy through in vitro fertilization (IVF). Most often, embryos with normal chromosome results are selected for transfer, with well established outcomes. Transferring an embryo with a non-euploid result (i.e., mosaic, isolated segmental aneuploid or aneuploidy of whole chromosome(s)) may be considered for a variety of patient specific reasons. However, little information is available on the long-term outcomes of mosaic embryo transfer. Even less has been published on outcomes for other types of non-euploid results.
The NEET Registry aims to collect prenatal, neonatal and pediatric outcome information for embryos transferred with the various types of non-euploid PGT-A results to support providers and patients in their decision making regarding such transfers.
We are seeking women who are planning or recently completed a non-euploid embryo transfer (NEET) at one of our participating fertility clinics.
Study participants must meet the following criteria:
All participants will sign the NEET Registry consent form via EngagedMD.
Participants with clinical pregnancy resulting from NEET will be asked to sign a medical release via EngagedMD so we may collect information on pregnancy, delivery and pediatric development.
Participants who deliver a baby post NEET will complete a brief electronic survey when the child is 2 months, 6 months, 1-year, 2-years and, 5-years of age.
Interested in participating in this study? Please complete this form to be considered.
